See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Alfonso Iorio

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	36891522	0	Shapiro AD, Hardesty BM, Peyvandi F, et al. Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review. Res Pract Thromb Haemost. 2022 Dec 9;7(1):100007. doi: 10.1016/j.rpth.2022.100007. eCollection 2023 Jan.
	35753074	0	Chelle P, Iorio A, Edginton AN. A personalized limited sampling approach to better estimate terminal half-life of FVIII concentrates. J Thromb Haemost. 2022 Sep;20(9):2012-2021. doi: 10.1111/jth.15803. Epub 2022 Jul 7.
	34878676	0	Olasupo OO, Haddix C, Nakar C, et al. Utilization of a surgical database to provide care and assess perioperative treatment and outcomes in patients with bleeding disorders. Eur J Haematol. 2021 Dec 8. doi: 10.1111/ejh.13731.
	34843861	0	Wiercioch W, Nieuwlaat R, Zhang Y, et al. New methods facilitated the process of prioritizing questions and health outcomes in guideline development. J Clin Epidemiol. 2021 Nov 26. pii: S0895-4356(21)00389-9. doi: 10.1016/j.jclinepi.2021.11.031.
	34521104	0	Nieuwlaat R, Wiercioch W, Brozek JL, et al. How to write a guideline: a proposal for a manuscript template that supports the creation of trustworthy guidelines. Blood Adv. 2021 Sep 14. pii: S2473-9529(21)00555-3. doi: 10.1182/bloodadvances.2020003577.
	33992716	0	Wiercioch W, Nieuwlaat R, Dahm P, et al. Development and application of health outcome descriptors facilitated decision-making in the production of practice guidelines. J Clin Epidemiol. 2021 May 13;138:115-127. doi: 10.1016/j.jclinepi.2021.04.016.
	33463024	0	Konkle B, Pierce G, Coffin D, et al. Core data set on safety, efficacy, and durability of hemophilia gene therapy for a global registry: Communication from the SSC of the ISTH. J Thromb Haemost. 2020 Nov;18(11):3074-3077. doi: 10.1111/jth.15023.
	33293309	0	Tritschler T, Langlois N, Hutton B, et al. Protocol for a scoping review of outcomes in clinical studies of interventions for venous thromboembolism in adults. BMJ Open. 2020 Dec 7;10(12):e040122. doi: 10.1136/bmjopen-2020-040122.
	33049056	0	Darzi AJ, Repp AB, Spencer FA, et al. Risk-assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews. Blood Adv. 2020 Oct 13;4(19):4929-4944. doi: 10.1182/bloodadvances.2020002482.
	32976752	0	Schunemann HJ, Ventresca M, Crowther M, et al. Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis. Lancet Haematol. 2020 Oct;7(10):e746-e755. doi: 10.1016/S2352-3026(20)30293-3.
	32914582	0	Zheng XL, Vesely SK, Cataland SR, et al. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura. J Thromb Haemost. 2020 Oct;18(10):2486-2495. doi: 10.1111/jth.15006. Epub 2020 Sep 11.
	32542391	0	Darzi AJ, Karam SG, Spencer FA, et al. Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment. Blood Adv. 2020 Jun 23;4(12):2557-2566. doi: 10.1182/bloodadvances.2020001937.
	32453843	0	Wiercioch W, Nieuwlaat R, Akl EA, et al. Methodology for the American Society of Hematology VTE guidelines: current best practice, innovations, and experiences. Blood Adv. 2020 May 26;4(10):2351-2365. doi: 10.1182/bloodadvances.2020001768.
	32428195	0	Paquette M, Mbuagbaw L, Iorio A, et al. Methodological considerations for investigating oral anticoagulation persistence in atrial fibrillation. Eur Heart J Cardiovasc Pharmacother. 2021 May 23;7(3):251-260. doi: 10.1093/ehjcvp/pvaa052.
	32336010	0	van Es N, Ventresca M, Di Nisio M, et al. The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis. J Thromb Haemost. 2020 Aug;18(8):1940-1951. doi: 10.1111/jth.14824. Epub 2020 Jul 8.
	32092132	0	Darzi AJ, Karam SG, Charide R, et al. Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis. Blood. 2020 May 14;135(20):1788-1810. doi: 10.1182/blood.2019003603.
	31368220	0	Makris M, Iorio A, Lenting PJ. Emicizumab and thrombosis: The story so far. J Thromb Haemost. 2019 Aug;17(8):1269-1272. doi: 10.1111/jth.14556.
	31282771	0	Escobar M, Santagostino E, Mancuso ME, et al. Switching patients in the age of long-acting recombinant products? Expert Rev Hematol. 2019;12(sup1):1-13. doi: 10.1080/17474086.2018.1564032.
	29274307	0	Chai-Adisaksopha C, Iorio A, Crowther MA, et al. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism. Am J Med. 2018 Apr;131(4):430-437. doi: 10.1016/j.amjmed.2017.11.042. Epub 2017 Dec 20.
	29136562	0	Chai-Adisaksopha C, Iorio A, Hillis C, et al. Warfarin resumption following anticoagulant-associated intracranial hemorrhage: A systematic review and meta-analysis. Thromb Res. 2017 Dec;160:97-104. doi: 10.1016/j.thromres.2017.11.001. Epub 2017 Nov 11.
	28503122	0	Korte W, Poon MC, Iorio A, et al. Thrombosis in Inherited Fibrinogen Disorders. Transfus Med Hemother. 2017 Apr;44(2):70-76. doi: 10.1159/000452864. Epub 2017 Mar 14.
	28450404	0	Middeldorp S, Iorio A. Oral contraceptive use is a provoking factor for venous thromboembolism. BMJ. 2017 Apr 27;357:j2073. doi: 10.1136/bmj.j2073.
	28387451	0	Iorio A, Fischer K, Makris M. Large scale studies assessing anti-factor VIII antibody development in previously untreated haemophilia A: what has been learned, what to believe and how to learn more. Br J Haematol. 2017 Jul;178(1):20-31. doi: 10.1111/bjh.14610. Epub 2017 Apr 7.
	28078351	0	Chai-Adisaksopha C, Linkins LA, ALKindi SY, et al. Outcomes of low-molecular-weight heparin treatment for venous thromboembolism in patients with primary and metastatic brain tumours. Thromb Haemost. 2017 Feb 28;117(3):589-594. doi: 10.1160/TH16-09-0680. Epub 2017 Jan 12.
	27488143	0	Chai-Adisaksopha C, Hillis C, Siegal DM, et al. Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. Thromb Haemost. 2016 Oct 28;116(5):879-890. doi: 10.1160/TH16-04-0266. Epub 2016 Aug 4.
	27130164	0	Schunemann HJ, Ventresca M, Crowther M, et al. Use of heparins in patients with cancer: individual participant data meta-analysis of randomised trials study protocol. BMJ Open. 2016 Apr 29;6(4):e010569. doi: 10.1136/bmjopen-2015-010569.
	26595784	0	Marcucci M, Skjoth F, Lip GY, et al. A decisional model to individualize warfarin recommendations: Expected impact on treatment and outcome rates in a real-world population with atrial fibrillation. Int J Cardiol. 2016 Jan 15;203:785-90. doi: 10.1016/j.ijcard.2015.11.035. Epub 2015 Nov 6.